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he reduced daily usage of nicotine gum to 16, 12, and 5 pieces,
respectively, while using 3, 7, and 14 pieces of placebo gum. During
week 6, he used no nicotine gum intake and averaged 17 pieces of
placebo gum per day. During week 7 the 19 pieces of gum he used
were divided between placebo gum and bubble gum. By week 8 and
at the six-month follow-up he was using only bubble gum. We
confirmed that he was not smoking (CO levels were negligible) and
that nicotine gum use had been eliminated as planned (cotinine
levels were 375, 66, and 0 [ < 20] ng/ml at weeks 2, 6, and 32,
respectively).
In this case a simple procedure enabled a patient to achieve
abstinence from nicotine gum without adverse effects such as
resuming cigarette smoking or nicotine withdrawal symptoms.
Whereas occasional use of nicotine gum may be required long-term
to prevent relapse to tobacco use in some people abstinence from
any source of nicotine is the target recommended by the
manufacturers of nicorette and that is what gum users and those
treating them aim for.1,2 Our experience suggests that it might be
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FORMS OF COCAINE AND PSYCHIATRIC
SYMPTOMS
SIR,-Dr Honer and colleagues (Aug 22, p 451) report an
increase in psychosis and violence among users of "crack" cocaine
compared with users of other forms of cocaine. They separated
crack users from "freebase" users, implying that crack and freebase
represent different forms of cocaine. This is untrue, of course,
because crack and freebase are chemically identical, consisting of
alkaloidal cocaine; also, both crack and freebase are typically
ingested by smoking.’ Therefore the differences they found
between their crack and freebase users most likley reflected
differences in other factors such as dose or demography. Although
Honer et al concede these possibilities, they present no data to
clarify the issue.
Contrary to the assertion by Honer and colleagues that
"symptoms among users of different forms of cocaine have not been
compared", we have reported such comparisons among 100 cocaine
users presenting to a psychiatric emnergency room.2 Our patients
were divided by their preferred method of ingestion into intranasal
(n =16), intravenous (n = 28), and smoking (n=56) groups. We
found no significant differences between the three groups in
psychotic symptoms (persecutory delusions and auditory, visual, or
tactile hallucinations) .2 Although not previously reported, our data
also failed to reveal any significant difference between the three
groups in violence, defined as physical harm to self or others. 19 %
of the intranasal group, 33 % of the intravenous group, and 36 % of
the smoking group reported violence. Further analysis of our data
showed that cocaine users with psychotic or violent symptoms used
more cocaine over more days in the month before interview than
users without these symptoms (table).
Our data support a model3 suggesting that psychotic and violent
symptoms from cocaine are associated with frequency of use and
PATTERN OF COCAINE USE AMONG COCAINE PATIENTS WITH AND
WITHOUT SYMPTOMS OF PSYCHOSIS AND VIOLENCE*
Findings given as mean (SD).
*n = 91, because 9 of the 100 patients had missing data.
Comparison between groups (two-tailed t test)&mdash;tp < 0 001 and t p < 0 on . 1
dose, irrespective of the form of cocaine used or the method of
ingestion. Cocaine smokers do tend to develop addictive patterns of
use at a faster rate than users of other ingestion methods,! and the
addictive patterns are marked by more frequent use and the
consumption of higher doses. Nevertheless, users of any form of
cocaine, ingested by any method, can suffer adverse effects ranging
from psychosis and violence to death.’ This is the critical message
for emergency-room personnel and their cocaine-using patients.
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PENICILLIN-RESISTANT BORRELIA ENCEPHALITIS
RESPONDING TO CEFOTAXIME
SiR,&mdash;The established treatment of neurological Lyme disease is
high-dose intravenous penicillin.1 In cases presumed resistant to
penicillin, ceftriaxone is effective.2 Because ceftriaxone is not
available in the UK and other Western European countries we were
prompted to use intravenous cefotaxime in a patient who was
positive for Borrelia burgdorferi antibodies and in whom no response
had been obtained with penicillin. 
’
A previously healthy 52-year-old man was admitted in June,
1987, after he had been found wandering in his garden, confused
and restless. He was irritable and disoriented in time and place and
had difficulty in concentration and a poor memory. His temperature
was 37’8&deg;C; he had no other physical abnormality. There was no
history of tick-bite, cutaneous eruption, or any neurological or other
systemic signs. Cerebrospinal fluid (CSF) contained increased
protein (0-62 g/1), normal glucose, and 3 leucocytes/ltl. Culture for
fungi, bacteria (including mycobacteria), and viruses were negative.
A computerised tomographic brain scan (CT) was normal.
Electro-encephalogram (EEG) showed generalised slow-wave
dysrhythmia in the delta range. He was treated with intravenous
acyclovir, 1 g daily, in divided doses for 7 days for possible herpes
encephalitis but without response. Herpes simplex antibody titre
was not significantly increased during the illness. An indirect
immunofluorescence test for antibodies to B burgdorferi 1 week after
admission showed a serum IgG titre of 512, which was confirmed2 2
weeks later when the IgG titre was 1024. IgM titres were negative in
both samples. No borrelial antibodies were found in CSF.
Auto-antibody Venereal Disease Research Laboratory and
Treponema pallidum haemagglutination assays were negative. 3
weeks after admission he was treated with intravenous benzyl-
penicillin, 20 MU daily in divided doses for 10 days without
response. 4 days after the end of the course of penicillin he had a
generalised seizure which was controlled with carbamazepine. At
this stage CSF contained increased protein (0-68 g/1), normal
glucose, and 2 leucocytes/ul. CT was normal and the IgG specific
antibody titre for B burgdorferi remained at 512. EEG showed
slow-wave dysrhythmia.
8 weeks after admission he was started on intravenous
cefotaxime, 2 g three times daily, and prednisolone, 40 mg daily.
